)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Sun Pharma Advanced Research Company
Sun Pharma Advanced Research Company (SPARC) investor relations material
Sun Pharma Advanced Research Company Q2 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 26/27 earnings summary2 Nov, 2026
Executive summary
Q2 FY27 revenue from operations was ₹3,003 lakh standalone and consolidated; H1 revenue was ₹6,995 lakh, with net losses of ₹2,458 lakh and ₹4,498 lakh, respectively, in Q2.
The Board approved unaudited standalone and consolidated Q2 and H1 results; auditors’ limited reviews found no matters indicating material misstatement.
Financial highlights
Standalone Q2 revenue from operations was ₹3,003 lakh versus ₹786 lakh YoY; total income was ₹5,365 lakh versus ₹787 lakh.
Consolidated Q2 revenue from operations was ₹3,003 lakh versus ₹786 lakh YoY; total income was ₹5,365 lakh versus ₹787 lakh.
Standalone H1 revenue was ₹6,995 lakh versus ₹1,750 lakh YoY; net loss narrowed to ₹4,556 lakh from ₹12,800 lakh.
Consolidated H1 revenue was ₹6,995 lakh versus ₹1,750 lakh YoY; net loss narrowed to ₹4,498 lakh from ₹12,760 lakh.
Segment performance
Pharmaceutical Research and Development was the sole reportable business segment.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sun Pharma Advanced Research Company
- Q1 FY27 saw normalized revenue and a net loss following a major one-time PRV sale in Q4.SPARC
Q1 26/27 - Exceptional PRV income drove a major profit rebound and strengthened equity in FY26.SPARCQ4 25/26
- Q3 FY26 net loss widened, revenue declined, and a US FDA PRV was granted for Sezaby®.SPARCQ3 25/26
- Lead programs SCD153 and MUC1 ADC/SBO-154 advance, driven by partnerships and cost savings.SPARCR&D Day 2026
- Losses narrowed but remain significant; promoter support continues to underpin operations.SPARCQ2 25/26
- Net loss narrowed in Q1 FY26 as revenue declined and R&D focus continued.SPARCQ1 25/26
- Prioritizing oncology and immunology assets, pursuing cash catalysts and clinical milestones.SPARCStatus Update
- Net loss deepened in Q2 FY25 amid falling revenues and persistent high expenses.SPARCQ2 24/25
- Net loss persists amid declining revenue, with operations supported by promoter group backing.SPARCQ1 24/25
Next Sun Pharma Advanced Research Company earnings date
Q3 26/278 Feb, 2027
Sun Pharma Advanced Research Company
Next Sun Pharma Advanced Research Company earnings date
Q3 26/278 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Sun Pharma Advanced Research Company Limited is a pharmaceutical research and development company focused on the discovery and advancement of new drug delivery systems, novel drug formulations, and innovative pharmaceutical technologies. The company conducts pre-clinical and clinical research across various therapeutic areas, supporting product innovation and lifecycle extension. Its activities include formulation development, intellectual property management, and collaboration with global partners for commercialization. Sun Pharma Advanced Research Company Limited operates independently of Sun Pharmaceutical Industries Limited. The company is headquartered in Mumbai, India, and its shares are listed on the NSE.